N-[6-[4-[1-[(4-chlorophenyl)methyl]piperidin-4-yl]-3-ethylpiperazin-1-yl]-5-methyl-3-pyridinyl]methanesulfonamide

C25H36ClN5O2S — CID 143279979

IUPACN-[6-[4-[1-[(4-chlorophenyl)methyl]piperidin-4-yl]-3-ethylpiperazin-1-yl]-5-methyl-3-pyridinyl]methanesulfonamide
SMILESCCC1CN(c2ncc(NS(C)(=O)=O)cc2C)CCN1C1CCN(Cc2ccc(Cl)cc2)CC1
InChIInChI=1S/C25H36ClN5O2S/c1-4-23-18-30(25-19(2)15-22(16-27-25)28-34(3,32)33)13-14-31(23)24-9-11-29(12-10-24)17-20-5-7-21(26)8-6-20/h5-8,15-16,23-24,28H,4,9-14,17-18H2,1-3H3
InChIKeyPLIRXECLCCECFP-UHFFFAOYSA-N
MW506.12 g/mol
LogP3.98
Rot. Bonds7

About N-[6-[4-[1-[(4-chlorophenyl)methyl]piperidin-4-yl]-3-ethylpiperazin-1-yl]-5-methyl-3-pyridinyl]methanesulfonamide

N-[6-[4-[1-[(4-chlorophenyl)methyl]piperidin-4-yl]-3-ethylpiperazin-1-yl]-5-methyl-3-pyridinyl]methanesulfonamide (PubChem CID 143279979) has the molecular formula C25H36ClN5O2S and a molecular weight of 506.12 g/mol. Its IUPAC name is N-[6-[4-[1-[(4-chlorophenyl)methyl]piperidin-4-yl]-3-ethylpiperazin-1-yl]-5-methyl-3-pyridinyl]methanesulfonamide.

Molecular Properties

Compound NameN-[6-[4-[1-[(4-chlorophenyl)methyl]piperidin-4-yl]-3-ethylpiperazin-1-yl]-5-methyl-3-pyridinyl]methanesulfonamide
PubChem CID143279979
Molecular FormulaC25H36ClN5O2S
Molecular Weight506.12 g/mol
Exact Mass505.23
IUPAC NameN-[6-[4-[1-[(4-chlorophenyl)methyl]piperidin-4-yl]-3-ethylpiperazin-1-yl]-5-methyl-3-pyridinyl]methanesulfonamide
SMILESCCC1CN(c2ncc(NS(C)(=O)=O)cc2C)CCN1C1CCN(Cc2ccc(Cl)cc2)CC1
InChIInChI=1S/C25H36ClN5O2S/c1-4-23-18-30(25-19(2)15-22(16-27-25)28-34(3,32)33)13-14-31(23)24-9-11-29(12-10-24)17-20-5-7-21(26)8-6-20/h5-8,15-16,23-24,28H,4,9-14,17-18H2,1-3H3
InChIKeyPLIRXECLCCECFP-UHFFFAOYSA-N
XLogP3.98
TPSA68.78 Ų
H-Bond Donors1
H-Bond Acceptors6
Rotatable Bonds7
Heavy Atoms34
Complexity—

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500506.12
LogP ≤ 53.98
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 106

Analyze N-[6-[4-[1-[(4-chlorophenyl)methyl]piperidin-4-yl]-3-ethylpiperazin-1-yl]-5-methyl-3-pyridinyl]methanesulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-[5-chloro-6-[(3S)-3-ethyl-4-[1-[(4-fluorophenyl)methyl]piperidin-4-yl]piperazin-1-yl]-3-pyridinyl]methanesulfonamide
CID 11853954
5-chloro-2-[[4-[(2S)-4-[3-chloro-5-(methanesulfonamido)-2-pyridinyl]-2-ethylpiperazin-1-yl]piperidin-1-yl]methyl]benzamide
CID 11853697
N-[5-chloro-6-[4-[1-[(4-chloro-2-cyanophenyl)methyl]piperidin-4-yl]-3-ethylpiperazin-1-yl]-3-pyridinyl]methanesulfonamide;ethane
CID 143280329
6-[4-[1-[[4-(2,2-difluoroethyl)phenyl]methyl]piperidin-4-yl]-3-ethylpiperazin-1-yl]-N,5-dimethylpyridin-3-amine
CID 143280196
N-[5-chloro-6-[(3S)-4-[1-[(4-chloro-2-methoxyphenyl)methyl]piperidin-4-yl]-3-propylpiperazin-1-yl]-3-pyridinyl]methanesulfonamide
CID 148799423
6-[3-ethyl-4-[1-[(2-fluoro-4-methylphenyl)methyl]piperidin-4-yl]piperazin-1-yl]-N,5-dimethylpyridin-3-amine
CID 143280464
bis(N-[6-[(3S)-4-[1-[(4-bromophenyl)methyl]piperidin-4-yl]-3-ethylpiperazin-1-yl]-5-chloro-3-pyridinyl]methanesulfonamide);3-[[5-chloro-6-[(3S)-4-[1-[(1S)-1-(4-chlorophenyl)-2-hydroxyethyl]piperidin-4-yl]-3-ethylpiperazin-1-yl]-3-pyridinyl]amino]-4-(cyclopropylamino)cyclobut-3-ene-1,2-dione;bis(3-[[5-chloro-6-[(3S)-4-[1-[(4-chlorophenyl)methyl]piperidin-4-yl]-3-ethylpiperazin-1-yl]-3-pyridinyl]amino]-4-(cyclopropylamino)cyclobut-3-ene-1,2-dione);bis(N-[5-chloro-6-[(3S)-4-[1-[(4-chlorophenyl)methyl]piperidin-4-yl]-3-ethylpiperazin-1-yl]-3-pyridinyl]methanesulfonamide)
CID 158847975
5-chloro-6-[(3S)-4-[1-[(4-chlorophenyl)methyl]piperidin-4-yl]-3-ethylpiperazin-1-yl]-N-propan-2-ylpyridine-3-carboxamide;molecular hydrogen
CID 161221227
5-chloro-6-[(3S)-4-[1-[(4-chlorophenyl)methyl]piperidin-4-yl]-3-ethylpiperazin-1-yl]-1,3-dihydroimidazo[4,5-b]pyrazin-2-one
CID 11997684
3-(cyclopropylamino)-4-[[6-[3-ethyl-4-[1-[(2-fluoro-4-methylphenyl)methyl]piperidin-4-yl]piperazin-1-yl]-5-methyl-3-pyridinyl]amino]cyclobut-3-ene-1,2-dione
CID 163547765
[6-[(3S)-4-[1-[(4-chlorophenyl)methyl]piperidin-4-yl]-3-ethylpiperazin-1-yl]-3-pyridinyl]methanamine
CID 59427716
3-amino-5-[4-[1-[(4-chlorophenyl)methyl]piperidin-4-yl]-3-ethylpiperazin-1-yl]-N,6-dimethylpyrazine-2-carboxamide
CID 143280991

Frequently Asked Questions

What is the IUPAC name of N-[6-[4-[1-[(4-chlorophenyl)methyl]piperidin-4-yl]-3-ethylpiperazin-1-yl]-5-methyl-3-pyridinyl]methanesulfonamide?
The IUPAC name of N-[6-[4-[1-[(4-chlorophenyl)methyl]piperidin-4-yl]-3-ethylpiperazin-1-yl]-5-methyl-3-pyridinyl]methanesulfonamide (CID 143279979) is N-[6-[4-[1-[(4-chlorophenyl)methyl]piperidin-4-yl]-3-ethylpiperazin-1-yl]-5-methyl-3-pyridinyl]methanesulfonamide.
What is the SMILES notation for N-[6-[4-[1-[(4-chlorophenyl)methyl]piperidin-4-yl]-3-ethylpiperazin-1-yl]-5-methyl-3-pyridinyl]methanesulfonamide?
The canonical SMILES for N-[6-[4-[1-[(4-chlorophenyl)methyl]piperidin-4-yl]-3-ethylpiperazin-1-yl]-5-methyl-3-pyridinyl]methanesulfonamide is CCC1CN(c2ncc(NS(C)(=O)=O)cc2C)CCN1C1CCN(Cc2ccc(Cl)cc2)CC1.
What is the InChIKey of N-[6-[4-[1-[(4-chlorophenyl)methyl]piperidin-4-yl]-3-ethylpiperazin-1-yl]-5-methyl-3-pyridinyl]methanesulfonamide?
The InChIKey is PLIRXECLCCECFP-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H36ClN5O2S/c1-4-23-18-30(25-19(2)15-22(16-27-25)28-34(3,32)33)13-14-31(23)24-9-11-29(12-10-24)17-20-5-7-21(26)8-6-20/h5-8,15-16,23-24,28H,4,9-14,17-18H2,1-3H3.
What are the key properties of N-[6-[4-[1-[(4-chlorophenyl)methyl]piperidin-4-yl]-3-ethylpiperazin-1-yl]-5-methyl-3-pyridinyl]methanesulfonamide?
N-[6-[4-[1-[(4-chlorophenyl)methyl]piperidin-4-yl]-3-ethylpiperazin-1-yl]-5-methyl-3-pyridinyl]methanesulfonamide has a molecular weight of 506.12 g/mol, XLogP of 3.98, 7 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for N-[6-[4-[1-[(4-chlorophenyl)methyl]piperidin-4-yl]-3-ethylpiperazin-1-yl]-5-methyl-3-pyridinyl]methanesulfonamide is sourced from PubChem (CID 143279979), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).